Information updates

ASCIA CSU Update

13 July 2020

Further to updates made in 2019, the ASCIA Chronic Spontaneous Urticaria (CSU) Position Paper and ASCIA CSU Treatment Guidelines for Australia have recently been updated, in response to difficulties in sourcing H2 antagonists.

The following statement has been included on page 16:

Furthermore, H2 antagonists are now difficult to source and the evidence base for efficacy in CSU is weak, so these should no longer be required as a step before allowing prescription of omalizumab.

Changes have also been made on page 19, and to the ASCIA CSU Treatment Guidelines for Australia.

The updated ASCIA CSU Position Paper and Treatment Guidelines are available on the ASCIA website www.allergy.org.au/hp/papers/chronic-spontaneous-urticaria-csu-guidelines

 

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.